Paper41997994
Antiretroviral therapy interferes with pseudovirus neutralization assays while Gag-specific T-cells influence mRNA vaccine outcomes in HIV patients.
Litwin SM and 22 others. Sci Rep, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Antiretroviral therapy interferes with pseudovirus neutralization assays while Gag-specific T-cells influence mRNA vaccine outcomes in HIV patients. Papers, record 41997994. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41997994
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antiretroviral therapy interferes with pseudovirus neutralization assays while Gag-specific T-cells influence mRNA vaccine outcomes in HIV patients.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HIV Infections | Major topic |
| gag Gene Products, Human Immunodeficiency Virus | Major topic |
| T-Lymphocytes | Major topic |
| COVID-19 Vaccines | Major topic |
| Anti-Retroviral Agents | Major topic |
| Humans | |
| Female | |
| Male | |
| Neutralization Tests | |
| Adult | |
| COVID-19 | |
| Middle Aged | |
| Antibodies, Neutralizing | |
| HIV-1 | |
| CD4-Positive T-Lymphocytes | |
| mRNA Vaccines | |
| SARS-CoV-2 |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P51 OD011104 | NIH HHS | United States | P51OD011104 | PubMed | NIH RePORTER |
| U54CA260581-01 | NIH HHS | United States | U54CA260581 | PubMed | NIH RePORTER |
References92
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38423018 | Bivalent mRNA COVID vaccines elicit predominantly cross-reactive CD4+ T cell clonotypes. | Cell Rep Med | 2024 | https://conductscience.org/library/papers/38423018 | PubMed |
| 2 | 34193870 | SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells. | Nat Commun | 2021 | https://conductscience.org/library/papers/34193870 | PubMed |
| 3 | 33322797 | IgA2 Antibodies against SARS-CoV-2 Correlate with NET Formation and Fatal Outcome in Severely Diseased COVID-19 Patients. | Cells | 2020 | https://conductscience.org/library/papers/33322797 | PubMed |
| 4 | 36536068 | Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection. | Nat Rev Immunol | 2023 | https://conductscience.org/library/papers/36536068 | PubMed |
| 5 | 19949327 | Immunization for HIV-positive individuals. | Curr Opin Infect Dis | 2010 | https://conductscience.org/library/papers/19949327 | PubMed |
| 6 | 33808066 | COVID-19 in People Living with HIV: A Systematic Review and Meta-Analysis. | Int J Environ Res Public Health | 2021 | https://conductscience.org/library/papers/33808066 | PubMed |
| 7 | 32585083 | An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening. | Curr Protoc Microbiol | 2020 | https://conductscience.org/library/papers/32585083 | PubMed |
| 8 | 37821620 | The immune response to SARS-CoV-2 in people with HIV. | Cell Mol Immunol | 2024 | https://conductscience.org/library/papers/37821620 | PubMed |
| 9 | 39223211 | T-cell responses to ancestral SARS-CoV-2 and Omicron variant among unvaccinated pregnant and postpartum women living with and without HIV in South Africa. | Sci Rep | 2024 | https://conductscience.org/library/papers/39223211 | PubMed |
| 10 | 35561704 | Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19. | Lancet HIV | 2022 | https://conductscience.org/library/papers/35561704 | PubMed |
| 11 | 37790941 | Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature. | Front Immunol | 2023 | https://conductscience.org/library/papers/37790941 | PubMed |
| 12 | 1358913 | Secretory immunoglobulins in serum from human immunodeficiency virus (HIV)-infected patients. | J Clin Immunol | 1992 | https://conductscience.org/library/papers/1358913 | PubMed |
| 13 | 31470903 | HIV infection drives IgM and IgG3 subclass bias in Plasmodium falciparum-specific and total immunoglobulin concentration in Western Kenya. | Malar J | 2019 | https://conductscience.org/library/papers/31470903 | PubMed |
| 14 | 19361304 | Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients. | Clin Infect Dis | 2009 | https://conductscience.org/library/papers/19361304 | PubMed |
| 15 | 34559854 | Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma. | PLoS Pathog | 2021 | https://conductscience.org/library/papers/34559854 | PubMed |
| 16 | 14871298 | Immunoglobulin levels amongst persons with and without human immunodeficiency virus type 1 infection in Uganda and Norway. | Scand J Immunol | 2004 | https://conductscience.org/library/papers/14871298 | PubMed |
| 17 | 27239760 | PD-1(+) and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals. | Nat Med | 2016 | https://conductscience.org/library/papers/27239760 | PubMed |
| 18 | 32979941 | Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19. | Cell | 2020 | https://conductscience.org/library/papers/32979941 | PubMed |
| 19 | 25489001 | Course and Clinical Significance of CD8+ T-Cell Counts in a Large Cohort of HIV-Infected Individuals. | J Infect Dis | 2015 | https://conductscience.org/library/papers/25489001 | PubMed |
| 20 | 36560539 | Immune Responses against the Omicron Variant of SARS-CoV-2 after a Third Dose of COVID-19 Vaccine in Patients Living with Human Immunodeficiency Virus (PLWH): Comparison with Healthcare Workers. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/36560539 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| IGHA1 | 3493 | PubTator's text mining | https://conductscience.org/library/genes/3493 | NCBI Gene |
| IGHG3 | 3502 | PubTator's text mining | https://conductscience.org/library/genes/3502 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41997994
GET https://conductscience.org/api/papers/v1/41997994/authors?page=2